Jefferies Credit Partners (“JCP”): 2025 Year in Review

Michelle Ross, Stempoint Capital CIO, joins ‘Closing Bell’ to talk her perspective on the Biotech sector, companies she is watching in the space, and more.

Michelle Ross, StemPoint Capital CIO, joins ‘Closing Bell’ to discuss the small and mid-cap biotech stocks, the patent cliff coming for the companies in the sector and much more.

Click to see a collection of charts pertaining to the digital assets landscape.